Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Fenofibric acid

Related Products

Hot Products

Name

Fenofibric acid

EINECS 255-626-9
CAS No. 42017-89-0 Density 1.287 g/cm3
PSA 63.60000 LogP 3.81300
Solubility N/A Melting Point 177-179 °C
Formula C17H15ClO4 Boiling Point 486.457 °C at 760 mmHg
Molecular Weight 318.757 Flash Point 248.001 °C
Transport Information N/A Appearance white to off-white solid
Safety 26-36/37/39 Risk Codes 36/37/38
Molecular Structure Molecular Structure of 42017-89-0 (Fenofibric acid) Hazard Symbols 2058973
Synonyms

2-[4'-(p-Chlorobenzoyl)phenoxy]-2-methylpropionic acid;2-[p-(p-Chlorobenzoyl)phenoxy]-2-methylpropionic acid;FNF acid;LF 153;LF 178 acid;NSC 281318;Procetofenic acid;a-1081;2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid;Propanoic acid,2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-;

Article Data 25

Fenofibric acid Synthetic route

49562-28-9

fenofibrate

42017-89-0

fenofibric acid

Conditions
ConditionsYield
With water; triethylamine; lithium bromide In acetonitrile for 7h; Heating;99%
With iodine; aluminium In acetonitrile at 80℃; for 18h;97%
With sodium hydroxide In methanol at 69.85℃; for 4h;85%
1159999-13-9

benzyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate

42017-89-0

fenofibric acid

Conditions
ConditionsYield
Stage #1: benzyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate With potassium hydroxide In ethanol for 16h; Heating / reflux;
Stage #2: With hydrogenchloride In water pH=1;
91%
2052-01-9

2-bromo-2-methylpropionic acid

42019-78-3

4-chloro-4'-hydroxybenzophenone

42017-89-0

fenofibric acid

Conditions
ConditionsYield
Stage #1: 4-chloro-4'-hydroxybenzophenone With sodium hydroxide In butanone at 50℃; for 1h;
Stage #2: 2-bromo-2-methylpropionic acid In butanone at 50℃; for 16h;
87%
Multistep reaction.;
67-66-3

chloroform

42019-78-3

4-chloro-4'-hydroxybenzophenone

67-64-1

acetone

42017-89-0

fenofibric acid

Conditions
ConditionsYield
Stage #1: 4-chloro-4'-hydroxybenzophenone; acetone With sodium hydroxide for 2h; Heating / reflux;
Stage #2: chloroform In acetone for 8h; Heating / reflux;
73%
With sodium hydroxide
With sodium hydroxide
67-66-3

chloroform

37404-23-2

2-(4-iodophenoxy)-2-methylpropanoic acid

1679-18-1

4-Chlorophenylboronic acid

42017-89-0

fenofibric acid

Conditions
ConditionsYield
With cesiumhydroxide monohydrate; sodium carbonate; sodium iodide; Trimethylacetic acid In ethylene glycol at 120℃; for 48h; Sealed tube; Green chemistry;72%
42019-08-9

2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropionic acid ethyl ester

42017-89-0

fenofibric acid

Conditions
ConditionsYield
With water; sodium hydroxide In ethanol at 25℃; Temperature;0.95 g
122-01-0

4-chloro-benzoyl chloride

42017-89-0

fenofibric acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aluminium trichloride
2: sodium hydroxide
View Scheme
Multi-step reaction with 3 steps
1.1: aluminum (III) chloride / toluene / 1.5 h / 0 °C / Inert atmosphere; Reflux
2.1: sodium hydroxide / butanone / 1 h / Reflux
2.2: 8 h / Reflux
3.1: sodium hydroxide / 4 h / Reflux
View Scheme
100-66-3

methoxybenzene

42017-89-0

fenofibric acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aluminium trichloride
2: sodium hydroxide
View Scheme
Multi-step reaction with 3 steps
1.1: aluminum (III) chloride / toluene / 1.5 h / 0 °C / Inert atmosphere; Reflux
2.1: sodium hydroxide / butanone / 1 h / Reflux
2.2: 8 h / Reflux
3.1: sodium hydroxide / 4 h / Reflux
View Scheme
49715-04-0

chlorosulfuric acid chloromethyl ester

42017-89-0

fenofibric acid

1094101-30-0

chloromethyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate

Conditions
ConditionsYield
Stage #1: fenofibric acid With tetra(n-butyl)ammonium hydrogensulfate; sodium hydrogencarbonate In water at 20℃; for 0.25h;
Stage #2: chlorosulfuric acid chloromethyl ester In dichloromethane; water at 20℃; Cooling with ice;
100%
42017-89-0

fenofibric acid

67-63-0

isopropyl alcohol

49562-28-9

fenofibrate

Conditions
ConditionsYield
With magneticnanosolidsuperacid In cyclohexane; water at 83 - 85℃; Reagent/catalyst; Temperature;97%
Stage #1: fenofibric acid; isopropyl alcohol With thionyl chloride for 7h; Reflux;
Stage #2: With potassium carbonate In water at 60 - 65℃;
96.6%
With macroporous strong acid cation exchange resin D001 In water; toluene at 110℃;92.4%

Fenofibric acid History

From the Department of Biochemistry, Cell Biology, and Metabolism (R.A., S.Y.), Nagoya City University Graduate School of Medical Sciences, Japan; Research and Development Institute (R.A.), Grelan Pharmaceutical Co., Tokyo, Japan; Division of Biosignaling (N.T., T.N.-M.), National Institute of Health Sciences, Tokyo, Japan; and Division of Applied Life Sciences (K.U.), Graduate School of Agriculture, Kyoto University, Japan.

Fenofibric acid Consensus Reports

 Fenofibric acid increased transcription of ABCA1 gene in a liver X receptor–dependent manner. Fibrates are widely used drugs to reduce plasma triglyceride and increase high-density lipoprotein. Their active forms, fibric acids, are peroxisome proliferator-activated receptor- activators, but no direct evidence has been demonstrated for their activation of ATP-binding cassette transporter A1 (ABCA1) in relation to clinically used fibrates. We investigated the reaction of fenofibric acid in this regard, finding that fenofibric acid increased transcription of ABCA1 gene in n liver X receptor–dependent manner.

Fenofibric acid Analytical Methods

Fenofibric acid was examined for the effect of increase of ABCA1 activity. It enhanced ABCA1 gene transcription and its protein level in macrophage cell line cells and fibroblasts and increased apolipoprotein A-I–mediated cellular lipid release, all in a dose-dependent manner. Enhancement of the gene transcription was examined by using a reporter assay system for liver X receptor responsive element (LXRE) and its inactive mutant. The results demonstrated that the effect of fenofibric acid is dependent on active LXRE.

Fenofibric acid Specification

The Fenofibric acid belongs to the product categories of Pharmacetical; Various Metabolites and Impurities; Intermediates & Fine Chemicals; Metabolites & Impurities; Pharmaceuticals; Aromatics. Its EINECS number is 255-626-9. What's more, its systematic name is 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid. Its classification codes are: (1)Anticholesteremic Agents; (2)Antilipemic agents; (3)Antimetabolites; (4)Drug / Therapeutic Agent. This chemical is used as pharmaceutical intermediates and intermediate of fenofibrate. It is the active metabolite of fenofibrate.

Physical properties of Fenofibric acid are:
(1)ACD/LogP: 3.992; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 1.60; (4)ACD/LogD (pH 7.4): 0.35; (5)ACD/BCF (pH 5.5): 2.55; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 14.17; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 4; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 63.6 Å2; (13)Index of Refraction: 1.585; (14)Molar Refractivity: 83.048 cm3; (15)Molar Volume: 247.696 cm3; (16)Polarizability: 32.923×10-24cm3; (17)Surface Tension: 49.10 dyne/cm; (18)Density: 1.287 g/cm3; (19)Flash Point: 248.001 °C; (20)Enthalpy of Vaporization: 79.223 kJ/mol; (21)Boiling Point: 486.457 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.

Safety Information of Fenofibric acid:
When you are using this chemical, please be cautious about it as the following: This chemical is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. When using it, you need to wear suitable protective clothing, gloves and eye/face protection.

You could convert the following datas into the molecular structure:
(1)SMILES: O=C(c1ccc(Cl)cc1)c2ccc(OC(C(=O)O)(C)C)cc2
(2)Std. InChI: InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)
(3)Std. InChIKey: MQOBSOSZFYZQOK-UHFFFAOYSA-N

Toxicity of Fenofibric acid are as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 500mg/kg (500mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 885, 1976.
mouse LD50 oral 1200mg/kg (1200mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 885, 1976.
rat LD50 intravenous 313mg/kg (313mg/kg) LUNGS, THORAX, OR RESPIRATION: PLEURAL THICKENING

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 23.
rat LD50 oral 1242mg/kg (1242mg/kg)   Drugs of the Future. Vol. 7, Pg. 229, 1982.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 42017-89-0